Search

Your search keyword '"Ungaro R."' showing total 567 results

Search Constraints

Start Over You searched for: Author "Ungaro R." Remove constraint Author: "Ungaro R."
567 results on '"Ungaro R."'

Search Results

2. The serum protein profile across the IBD spectrum : Results from the COLLIBRI consortium

3. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

6. DOP05 Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´s Disease

13. P1177 Perceptions of patients with Inflammatory Bowel Disease and first degree relatives on prediction and prevention of disease

15. P683 Economic impact of achieving mucosal healing on UC-related hospitalisations and work productivity in patients with moderately to severely active UC: A post-hoc analysis of risankizumab Phase 2b/3 trials

16. P226 Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´s Disease Cohort) study

18. Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy

20. External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019

21. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment

22. Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment

23. Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation

25. P299 Disability in newly diagnosed patients with Crohn′s Disease: initial results from the prospective CROCO (Crohn′s Disease Cohort) Study

27. DOP051 Shorter disease duration is associated with higher response rates to vedolizumab in Crohn’s disease but not ulcerative colitis: a multi-centre consortium analysis

28. DOP012 Disease demarcation in ulcerative colitis is associated with different patterns of gene expression

29. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment

30. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients

37. Biomarkers for IBD using OLINK Proteomics inflammation panel : Preliminary results from the COLLIBRI consortium

38. Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach

39. Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach

40. Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach.

41. Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome

44. Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment

48. P521 Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial

49. P486 Treatment-emergent COVID-19 infections in ozanimod ulcerative colitis and multiple sclerosis clinical trials

Catalog

Books, media, physical & digital resources